Navidea Biopharmaceuticals (NAVB) to Announce First Quarter 2013 Financial Results Pre-Market on Wednesday, May 8, 2013
5/6/2013 7:06:07 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that the Company will report its financial results for the first quarter of 2013, on Wednesday, May 8, 2013 before the market opens. The announcement will be followed by a conference call with the investment community, also on Wednesday, May 8, 2013, at 8:30 a.m. EDT, to provide a business update and discuss the Company’s financial and operational results.
Help employers find you! Check out all the jobs and post your resume.
comments powered by